Total Payments
$1,494
2023 Payments
$21.86
Companies
16
Transactions
87
Medicare Patients
1,242
Medicare Billing
$166,665
Payment Breakdown by Category
Food & Beverage$1,494 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,494 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $401.35 | 24 | $0 (2020) |
| PFIZER INC. | $152.73 | 12 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $149.56 | 9 | $0 (2018) |
| Pulmonx Corporation | $142.15 | 1 | $0 (2020) |
| Mylan Specialty L.P. | $126.83 | 10 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $119.83 | 2 | $0 (2017) |
| Genentech USA, Inc. | $113.61 | 8 | $0 (2019) |
| Grifols USA, LLC | $109.99 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $48.14 | 4 | $0 (2019) |
| Boston Scientific Corporation | $32.28 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.86 | 1 | Boston Scientific Corporation ($21.86) |
| 2022 | $32.35 | 2 | PFIZER INC. ($32.35) |
| 2021 | $59.31 | 4 | PFIZER INC. ($31.23) |
| 2020 | $247.40 | 7 | Pulmonx Corporation ($142.15) |
| 2019 | $299.71 | 17 | GlaxoSmithKline, LLC. ($166.34) |
| 2018 | $347.74 | 24 | Actelion Pharmaceuticals US, Inc. ($90.41) |
| 2017 | $485.21 | 32 | GlaxoSmithKline, LLC. ($137.31) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: General - DBS_NMD | ||||||
| 06/21/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: VACCINES | ||||||
| 03/04/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: VACCINES | ||||||
| 12/17/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: VACCINES | ||||||
| 10/18/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: VACCINES | ||||||
| 06/18/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/26/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Respiratory and Allergy | ||||||
| 11/16/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Respiratory and Allergy | ||||||
| 10/05/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Food and Beverage | Cash or cash equivalent | $142.15 | General |
| Category: Pulmonology | ||||||
| 12/17/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Pulmonology | ||||||
| 10/09/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Pulmonology | ||||||
| 10/03/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Immunology | ||||||
| 07/17/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Pulmonology | ||||||
| 05/22/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Respiratory | ||||||
| 04/23/2019 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Respiratory and Allergy | ||||||
| 04/18/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Respiratory | ||||||
| 04/11/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: RESPIRATORY | ||||||
| 04/09/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 410 | 532 | $160,703 | $43,301 |
| 2022 | 11 | 280 | 358 | $122,735 | $33,606 |
| 2021 | 10 | 276 | 438 | $176,327 | $50,974 |
| 2020 | 9 | 276 | 391 | $131,967 | $38,785 |
Total Patients
1,242
Total Services
1,719
Medicare Billing
$166,665
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 60 | 116 | $70,180 | $18,800 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 93 | $27,063 | $8,052 | 29.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 73 | $20,732 | $6,422 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $10,584 | $2,583 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $7,056 | $2,379 | 33.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $9,900 | $2,373 | 24.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 18 | 18 | $8,586 | $1,407 | 16.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 31 | 31 | $1,023 | $197.36 | 19.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 23 | 23 | $1,012 | $193.82 | 19.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 17 | $833.00 | $169.92 | 20.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 25 | 25 | $750.00 | $148.56 | 19.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 16 | 16 | $704.00 | $145.12 | 20.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 18 | 18 | $594.00 | $120.96 | 20.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 16 | 16 | $752.00 | $112.32 | 14.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 11 | 11 | $484.00 | $103.40 | 21.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 15 | 15 | $450.00 | $92.85 | 20.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 55 | 110 | $66,550 | $18,302 | 27.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 47 | $13,348 | $3,699 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 45 | $9,675 | $2,939 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 21 | $6,111 | $2,054 | 33.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 14 | 20 | $6,080 | $1,683 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $5,967 | $1,563 | 26.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 12 | 12 | $5,724 | $1,244 | 21.7% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2022 | 13 | 14 | $5,572 | $1,152 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 11 | $1,540 | $505.34 | 32.8% |
About Dr. William Mariencheck, MD
Dr. William Mariencheck, MD is a Pulmonary Disease healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114995909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Mariencheck, MD has received a total of $1,494 in payments from pharmaceutical and medical device companies, with $21.86 received in 2023. These payments were reported across 87 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,494).
As a Medicare-enrolled provider, Mariencheck has provided services to 1,242 Medicare beneficiaries, totaling 1,719 services with total Medicare billing of $166,665. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Winston Salem, NC
- Active Since 03/09/2006
- Last Updated 08/09/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1114995909
Products in Payments
- NUCALA (Biological) $175.57
- Pulmonx Endobronchial Valve EBV (Device) $142.15
- OPSUMIT MACITENTAN (Drug) $131.19
- OFEV (Drug) $119.83
- TRELEGY ELLIPTA (Drug) $107.44
- ELIQUIS (Drug) $89.15
- Yupelri (Drug) $75.90
- Esbriet (Biological) $69.36
- Prolastin-C (Biological) $55.67
- ANORO (Drug) $54.69
- Prolastin-C Liquid (Biological) $54.32
- Perforomist (Drug) $50.93
- PREVNAR 20 (Biological) $49.34
- Xolair (Biological) $44.25
- BREO (Drug) $34.88
- FASENRA (Drug) $25.36
- QVAR (Drug) $24.44
- SYMBICORT (Drug) $22.78
- BREO ELLIPTA (Drug) $18.40
- UPTRAVI (Drug) $18.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Winston Salem
Jill Ohar, Md, MD
Pulmonary Disease — Payments: $365,275
Pulmonary Disease $365,275
Victor Ortega, M.d, M.D
Pulmonary Disease — Payments: $48,918
Pulmonary Disease $48,918
Kapilkumar Patel, M.d, M.D
Pulmonary Disease — Payments: $30,104
Pulmonary Disease $30,104
Dr. Christina Bellinger, Md, MD
Pulmonary Disease — Payments: $19,514
Pulmonary Disease $19,514
Dr. Benjamin Bregman, M.d, M.D
Pulmonary Disease — Payments: $13,437
Pulmonary Disease $13,437
Dr. Farhan Ahmed, M.d, M.D
Pulmonary Disease — Payments: $8,257
Pulmonary Disease $8,257